These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17360557)

  • 1. Haplotype structure and selection of the MDM2 oncogene in humans.
    Atwal GS; Bond GL; Metsuyanim S; Papa M; Friedman E; Distelman-Menachem T; Ben Asher E; Lancet D; Ross DA; Sninsky J; White TJ; Levine AJ; Yarden R
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4524-9. PubMed ID: 17360557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of functional DNA variants in the constitutive promoter region of MDM2.
    Lalonde ME; Ouimet M; Larivière M; Kritikou EA; Sinnett D
    Hum Genomics; 2012 Sep; 6(1):15. PubMed ID: 23244604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
    Gansmo LB; Lie BA; Mæhlen MT; Vatten L; Romundstad P; Hveem K; Lønning PE; Knappskog S
    Gene; 2021 Aug; 793():145747. PubMed ID: 34077778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations.
    Nechushtan H; Hamburger T; Mendelson S; Kadouri L; Sharon N; Pikarsky E; Peretz T
    BMC Cancer; 2009 Feb; 9():60. PubMed ID: 19226467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression?
    Tuna G; Küçükhüseyin O; Arıkan S; Kaytan Sağlam E; Güler E; Cacına C; Oztop O; Turan S; Korkmaz G; Yaylım I
    DNA Cell Biol; 2013 Jul; 32(7):400-8. PubMed ID: 23777425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma.
    Acun T; Terzioğlu-Kara E; Konu O; Ozturk M; Yakicier MC
    Mutat Res; 2010 Feb; 684(1-2):106-8. PubMed ID: 19954744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 SNP309 and SNP354 are not associated with lung cancer risk.
    Pine SR; Mechanic LE; Bowman ED; Welsh JA; Chanock SC; Shields PG; Harris CC
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1559-61. PubMed ID: 16896050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients.
    Tornesello ML; Buonaguro L; Cristillo M; Biryahwaho B; Downing R; Hatzakis A; Alessi E; Cusini M; Ruocco V; Viviano E; Romano N; Katongole-Mbidde E; Buonaguro FM
    Biomarkers; 2011 Feb; 16(1):42-50. PubMed ID: 20979563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.
    Paulin FE; O'Neill M; McGregor G; Cassidy A; Ashfield A; Ali CW; Munro AJ; Baker L; Purdie CA; Lane DP; Thompson AM
    BMC Cancer; 2008 Oct; 8():281. PubMed ID: 18828900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.
    Onel KB; Huo D; Hastings D; Fryer-Biggs J; Crow MK; Onel K
    Lupus; 2009 Jan; 18(1):61-6. PubMed ID: 19074170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of breast cancer outcome with status of p53 and MDM2 SNP309.
    Boersma BJ; Howe TM; Goodman JE; Yfantis HG; Lee DH; Chanock SJ; Ambs S
    J Natl Cancer Inst; 2006 Jul; 98(13):911-9. PubMed ID: 16818855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 SNP309 associates with accelerated pancreatic adenocarcinoma formation.
    Grochola LF; Müller TH; Bond GL; Taubert H; Udelnow A; Würl P
    Pancreas; 2010 Jan; 39(1):76-80. PubMed ID: 19752772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.
    Hu W; Feng Z; Ma L; Wagner J; Rice JJ; Stolovitzky G; Levine AJ
    Cancer Res; 2007 Mar; 67(6):2757-65. PubMed ID: 17363597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study.
    Assmann G; Voswinkel J; Mueller M; Bittenbring J; Koenig J; Menzel A; Pfreundschuh M; Roemer K; Melchers I
    Clin Exp Rheumatol; 2009; 27(4):615-9. PubMed ID: 19772793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
    Wan Y; Wu W; Yin Z; Guan P; Zhou B
    BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
    Kafadar A; Küçükhüseyin Ö; Turan S; Yenilmez EN; Tunoglu S; Zeybek U; Kaynar MY; Kemerdere R; Yaylim I
    Anticancer Res; 2015 Jul; 35(7):3933-42. PubMed ID: 26124340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2007 Feb; 120(3):563-5. PubMed ID: 17096342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
    Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
    Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians.
    Bittenbring J; Parisot F; Wabo A; Mueller M; Kerschenmeyer L; Kreuz M; Truemper L; Landt O; Menzel A; Pfreundschuh M; Roemer K
    BMC Cancer; 2008 Apr; 8():116. PubMed ID: 18433491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.